Chemours (NYSE:CC) Given New $19.00 Price Target at Barclays

Chemours (NYSE:CC - Get Free Report) had its target price lowered by equities research analysts at Barclays from $23.00 to $19.00 in a report issued on Monday,Benzinga reports. The firm presently has an "equal weight" rating on the specialty chemicals company's stock. Barclays's price objective points to a potential upside of 25.05% from the stock's current price.

CC has been the topic of several other research reports. Mizuho cut their target price on Chemours from $22.00 to $21.00 and set a "neutral" rating on the stock in a research report on Tuesday, January 7th. Morgan Stanley cut their price objective on shares of Chemours from $25.00 to $22.00 and set an "equal weight" rating on the stock in a report on Monday, January 13th. BMO Capital Markets lowered their target price on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a report on Wednesday, February 19th. Royal Bank of Canada reiterated an "outperform" rating and set a $25.00 price target on shares of Chemours in a research note on Thursday, December 12th. Finally, Truist Financial began coverage on shares of Chemours in a research report on Tuesday, January 28th. They issued a "buy" rating and a $27.00 price target for the company. Five analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $23.11.

Chemours Stock Down 5.0 %

Chemours stock traded down $0.81 during trading on Monday, reaching $15.19. The stock had a trading volume of 2,003,698 shares, compared to its average volume of 1,844,147. The company has a quick ratio of 0.92, a current ratio of 1.68 and a debt-to-equity ratio of 6.70. Chemours has a 52-week low of $14.94 and a 52-week high of $29.21. The stock has a market cap of $2.27 billion, a PE ratio of 26.66 and a beta of 1.81. The business has a 50 day moving average price of $17.91 and a 200 day moving average price of $18.84.

Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. The business had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.37 billion. Chemours had a net margin of 1.51% and a return on equity of 26.54%. On average, analysts predict that Chemours will post 2.03 EPS for the current year.

Institutional Trading of Chemours

Hedge funds have recently added to or reduced their stakes in the stock. Blue Trust Inc. lifted its holdings in shares of Chemours by 166.9% during the third quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company's stock worth $26,000 after purchasing an additional 731 shares during the period. GAMMA Investing LLC raised its position in Chemours by 99.7% during the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock worth $26,000 after buying an additional 765 shares during the last quarter. Truvestments Capital LLC purchased a new stake in shares of Chemours in the third quarter valued at about $35,000. Brooklyn Investment Group acquired a new position in shares of Chemours during the third quarter worth about $37,000. Finally, Quadrant Capital Group LLC raised its holdings in Chemours by 100.4% during the fourth quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company's stock worth $38,000 after purchasing an additional 1,119 shares in the last quarter. 76.26% of the stock is owned by institutional investors and hedge funds.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.